Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Giorgino

Showing results (91-100 of 102) with videos related to

Pageof 11
Sort By:
Acta Diabetologica|October 10, 2024
Glucose metrics and device satisfaction in adults with type 1 diabetes using different treatment modalities: a multicenter, real-world observational studyS Di Molfetta, A Rossi, R Gesuita, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|February 5, 2011
Metabolic syndrome in subjects at high risk for type 2 diabetes: the genetic, physiopathology and evolution of type 2 diabetes (GENFIEV) studyC Bianchi, R Miccoli, R C Bonadonna, et al.
Journal of Endocrinological Investigation|November 24, 2022
The physiological sonographic features of the ovary in healthy subjects: a joint systematic review and meta-analysis by the Italian Society of Gynecology and Obstetrics (SIGO) and the Italian Society of Endocrinology (SIE)F Moro, I Scavello, E Maseroli, et al.
ESMO Open|May 13, 2021
Antineoplastic dosing in overweight and obese cancer patients: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società Italiana Endocrinologia (SIE)/Società Italiana Farmacologia (SIF) multidisciplinary consensus position paperN Silvestris, A Argentiero, A Natalicchio, et al.
ESMO Open|May 21, 2021
Early prediction of pancreatic cancer from new-onset diabetes: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società Italiana Endocrinologia (SIE)/Società Italiana Farmacologia (SIF) multidisciplinary consensus position paperM Gallo, V Adinolfi, L Morviducci, et al.
ESMO Open|June 1, 2023
MiRNA dysregulation underlying common pathways in type 2 diabetes and cancer development: an Italian Association of Medical Oncology (AIOM)/Italian Association of Medical Diabetologists (AMD)/Italian Society of Diabetology (SID)/Italian Society of Endocrinology (SIE)/Italian Society of Pharmacology (SIF) multidisciplinary critical viewA Natalicchio, M Montagnani, M Gallo, et al.
ESMO Open|December 9, 2023
Diabetes management in cancer patients. An Italian Association of Medical Oncology, Italian Association of Medical Diabetologists, Italian Society of Diabetology, Italian Society of Endocrinology and Italian Society of Pharmacology multidisciplinary consensus position paperN Silvestris, T Franchina, M Gallo, et al.
Journal of Endocrinological Investigation|June 27, 2024
Glycemic control and cancer outcomes in oncologic patients with diabetes: an Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE), Italian Society of Pharmacology (SIF) multidisciplinary critical viewA Natalicchio, N Marrano, M Montagnani, et al.
Journal of Endocrinological Investigation|November 8, 2014
Rare diseases in clinical endocrinology: a taxonomic classification systemG Marcucci, L Cianferotti, P Beck-Peccoz, et al.
European Journal of Nutrition|December 23, 2016
Dietary intake and major food sources of polyphenols in people with type 2 diabetes: The TOSCA.IT StudyM Vitale, M Masulli, A A Rivellese, et al.
Pageof 11

Showing results (91-100 of 102) with videos related to

Sort By:
Pageof 11
Acta Diabetologica|October 10, 2024
Glucose metrics and device satisfaction in adults with type 1 diabetes using different treatment modalities: a multicenter, real-world observational studyS Di Molfetta, A Rossi, R Gesuita, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|February 5, 2011
Metabolic syndrome in subjects at high risk for type 2 diabetes: the genetic, physiopathology and evolution of type 2 diabetes (GENFIEV) studyC Bianchi, R Miccoli, R C Bonadonna, et al.
Journal of Endocrinological Investigation|November 24, 2022
The physiological sonographic features of the ovary in healthy subjects: a joint systematic review and meta-analysis by the Italian Society of Gynecology and Obstetrics (SIGO) and the Italian Society of Endocrinology (SIE)F Moro, I Scavello, E Maseroli, et al.
ESMO Open|May 13, 2021
Antineoplastic dosing in overweight and obese cancer patients: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società Italiana Endocrinologia (SIE)/Società Italiana Farmacologia (SIF) multidisciplinary consensus position paperN Silvestris, A Argentiero, A Natalicchio, et al.
ESMO Open|May 21, 2021
Early prediction of pancreatic cancer from new-onset diabetes: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società Italiana Endocrinologia (SIE)/Società Italiana Farmacologia (SIF) multidisciplinary consensus position paperM Gallo, V Adinolfi, L Morviducci, et al.
ESMO Open|June 1, 2023
MiRNA dysregulation underlying common pathways in type 2 diabetes and cancer development: an Italian Association of Medical Oncology (AIOM)/Italian Association of Medical Diabetologists (AMD)/Italian Society of Diabetology (SID)/Italian Society of Endocrinology (SIE)/Italian Society of Pharmacology (SIF) multidisciplinary critical viewA Natalicchio, M Montagnani, M Gallo, et al.
ESMO Open|December 9, 2023
Diabetes management in cancer patients. An Italian Association of Medical Oncology, Italian Association of Medical Diabetologists, Italian Society of Diabetology, Italian Society of Endocrinology and Italian Society of Pharmacology multidisciplinary consensus position paperN Silvestris, T Franchina, M Gallo, et al.
Journal of Endocrinological Investigation|June 27, 2024
Glycemic control and cancer outcomes in oncologic patients with diabetes: an Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE), Italian Society of Pharmacology (SIF) multidisciplinary critical viewA Natalicchio, N Marrano, M Montagnani, et al.
Journal of Endocrinological Investigation|November 8, 2014
Rare diseases in clinical endocrinology: a taxonomic classification systemG Marcucci, L Cianferotti, P Beck-Peccoz, et al.
European Journal of Nutrition|December 23, 2016
Dietary intake and major food sources of polyphenols in people with type 2 diabetes: The TOSCA.IT StudyM Vitale, M Masulli, A A Rivellese, et al.
Pageof 11